172 related articles for article (PubMed ID: 20455850)
1. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer.
Matthes H; Friedel WE; Bock PR; Zänker KS
Curr Mol Med; 2010 Jun; 10(4):430-9. PubMed ID: 20455850
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
[TBL] [Abstract][Full Text] [Related]
3. Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.
Mansky PJ; Grem J; Wallerstedt DB; Monahan BP; Blackman MR
Integr Cancer Ther; 2003 Dec; 2(4):345-52. PubMed ID: 14713326
[TBL] [Abstract][Full Text] [Related]
4. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
5. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
7. Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract.
Ritter PR; Tischoff I; Uhl W; Schmidt WE; Meier JJ
Onkologie; 2010; 33(11):617-9. PubMed ID: 20975309
[TBL] [Abstract][Full Text] [Related]
8. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
11. Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.
Bock PR; Hanisch J; Matthes H; Zänker KS
Inflamm Allergy Drug Targets; 2014; 13(2):105-11. PubMed ID: 24766319
[TBL] [Abstract][Full Text] [Related]
12. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
13. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
Friedel WE; Matthes H; Bock PR; Zänker KS
J Soc Integr Oncol; 2009; 7(4):137-45. PubMed ID: 19883529
[TBL] [Abstract][Full Text] [Related]
15. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
16. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
17. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
[TBL] [Abstract][Full Text] [Related]
18. Treatment effect or secret nature: long-term remissions in metastatic pancreatic cancer.
Horneber M
Onkologie; 2010; 33(11):581-2. PubMed ID: 20975303
[No Abstract] [Full Text] [Related]
19. Patients are talking about ... Iscador (mistletoe).
Decker G
Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
Braedel-Ruoff S
Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]